abacavir [nnon, phsu]
Lamivudine [nnon, phsu]
treatment [ftcn]
Human [humn]
IMMUNO-DEFICIENCY [dsyn]
Virus [virs]
Introduction [hlca]
Introduction [hlca]
Combination Therapy [topp]
Changed [ftcn]
Survival [acty]
Quality [qlco]
Life [idcn]
People [popg]
Living [idcn]
Virus, Human Immunodeficiency [virs]
viral replication [orgf]
Controlled [ftcn]
Using [ftcn]
Combination [qlco]
More [ftcn]
Licensed [rnlw]
Drugs [phsu]
Advance [medd]
Make [ftcn]
Last [qlco]
experience [menp]
Certain [qlco]
Needs [qlco]
To [qlco]
Address [inpr]
Presence [topp]
Chronic inflammation [patf]
Long-Term Effect [phpr]
Side [spco]
newly [idcn]
introduce [ftcn]
Drugs [phsu]
abacavir [nnon, phsu]
[c] [qnco]
Lamivudine [nnon, phsu]
Licensed [rnlw]
Fixed [fndg]
Dose [qnco]
Combination [qlco]
Administered [ftcn]
Once daily [tmco]
Anti-Retroviral Agents [phsu]
treatment [ftcn]
Virus, Human Immunodeficiency [virs]
Covered [ftcn]
This [euka]
Article [inpr]
Extensive [qlco]
Review [inpr]
Evidence [ftcn]
Combination [qlco]
mg% [qnco]
mg% [qnco]
Chemistry [ocdi]
Including [ftcn]
Resistance [menp]
treatment [ftcn]
Pharmacokinetics [phsf]
Metabolism [orgf]
Formulation [resa]
Available [ftcn]
Looks [orga]
Clinical [qlco]
Efficacy [qlco]
Including [ftcn]
Safety [hcpp]
TOLERABILITY [resa]
Expert Opinion [cnce]
Last [qlco]
New [tmco]
Data [idcn]
Human Leukocyte Antigen [aapp, imft]
Testing [ftcn]
To [qlco]
PREVENT [phsu]
Hypersensitivity reaction [patf]
Presented [idcn]
Provide [acty]
Management [ocac]
adverse events [fndg]
Virus, Human Immunodeficiency [virs]
Correlation [qlco]
Recent [tmco]
Exposure NOS [inpo]
Increased [qnco]
Risk [qlco]
Cardiovascular disease [dsyn]
This [euka]
Review [inpr]
Present [qnco]
Current [tmco]
Long-term [tmco]
Efficacy [qlco]
Safety [hcpp]
Data [idcn]
Combination [qlco]
